Venus Remedies
Venus Remedies Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Venus Remedies
Start SIPVenus Remedies Investment Rating
-
Master Rating:
-
Venus Remedies has an operating revenue of Rs. 541.80 Cr. on a trailing 12-month basis. An annual revenue growth of 7% is good, Pre-tax margin of 6% is okay, ROE of 9% is fair but needs improvement. The company has a reasonable debt to equity of 9%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and around 5% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 15 which is a POOR score indicating inconsistency in earnings, a RS Rating of 30 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 91 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 109 | 125 | 155 | 128 |
| Operating Expenses Qtr Cr | 102 | 110 | 137 | 121 |
| Operating Profit Qtr Cr | 7 | 15 | 18 | 7 |
| Depreciation Qtr Cr | 7 | 9 | 8 | 7 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 1 | 0 | 1 | 0 |
| Net Profit Qtr Cr | 3 | 8 | 11 | 2 |
Venus Remedies Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 11
- Bearish Moving Average
- ___
- 5
- 20 Day
- 161.33
- 50 Day
- 164.67
- 100 Day
- 175.98
- 200 Day
- 202.56
- 20 Day
- 163.05
- 50 Day
- 161.14
- 100 Day
- 176.78
- 200 Day
- 194.59
Venus Remedies Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 176.5 |
| Second Resistance | 183.35 |
| Third Resistance | 191.6 |
| RSI | 58.77 |
| MFI | 35.03 |
| MACD Single Line | -0.07 |
| MACD | 0.21 |
| Support | |
|---|---|
| First Resistance | 161.4 |
| Second Resistance | 153.15 |
| Third Resistance | 146.31 |
Venus Remedies Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 82,401 | 4,612,808 | 55.98 |
| Week | 64,724 | 4,501,540 | 69.55 |
| 1 Month | 72,288 | 3,590,543 | 49.67 |
| 6 Month | 42,151 | 2,416,506 | 57.33 |
Venus Remedies Result Highlights
Venus Remedies Synopsis
NSE-Medical-Diversified
Venus Remedies L is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 575.18 Cr. and Equity Capital is Rs. 13.37 Cr. for the Year ended 31/03/2022. Venus Remedies Ltd. is a Public Limited Listed company incorporated on 15/09/1989 and has its registered office in the State of Chandigarh, India. Company’s Corporate Identification Number(CIN) is L24232CH1989PLC009705 and registration number is 009705.| Market Cap | 226 |
| Sales | 517 |
| Shares in Float | 0.78 |
| No of funds | 7 |
| Yield |
| Book Value | 0.5 |
| U/D Vol ratio | 1 |
| LTDebt / Equity | 9 |
| Alpha | -0.24 |
| Beta | 1 |
Venus Remedies
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 41.76% | 41.76% | 41.76% | |
| Mutual Funds | ||||
| Foreign Portfolio Investors | 1.07% | 1.13% | 0.96% | |
| Individual Investors | 50.05% | 50.18% | 49.97% | |
| Others | 7.12% | 6.93% | 7.31% |
Venus Remedies Management
| Name | Designation |
|---|---|
| Mr. Pawan Chaudhary | Chairman & Managing Director |
| Dr.(Mrs.) Manu Chaudhary | Joint Managing Director |
| Mr. Peeyush Jain | Deputy Managing Director |
| Mr. Ashutosh Jain | Executive Director |
| Mr. Navdeep Sud | Independent Director |
| Dr. Gilbert Wenzel | Non Executive Director |
| Dr. S K Chadha | Independent Director |
| Mr. Pravindra Singh Chauhan | Independent Director |
| Dr.(Mrs.) Savita Gupta | Independent Director |
| Mr. Akshansh Chaudhary | Executive Director |
Venus Remedies Forecast
Price Estimates
Venus Remedies FAQs
What is Share Price of Venus Remedies ?
Venus Remedies share price is ₹166 As on 23 March, 2023 | 12:54
What is the Market Cap of Venus Remedies ?
The Market Cap of Venus Remedies is ₹222.2 Cr As on 23 March, 2023 | 12:54
What is the P/E ratio of Venus Remedies ?
The P/E ratio of Venus Remedies is 14.1 As on 23 March, 2023 | 12:54
What is the PB ratio of Venus Remedies ?
The PB ratio of Venus Remedies is 0.5 As on 23 March, 2023 | 12:54